Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 30)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
23-Apr-14New Constructs, LLCN/ACUR: Due Diligence Review: Forensic Earnings and Valuation5$25  View Abstract
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - DIAGNOCURE INC. (CUR-T)11$25  View Abstract
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - NEURALSTEM, INCORPORATION. (CUR-A)11$25  View Abstract
22-Apr-14Streetwise ReportsRaghuram SelvarajuNeuralstem Inc.: Moving from Strength to Strength2$11.50  View Abstract
22-Apr-14Streetwise ReportsRaghuram SelvarajuDo the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases11$115  View Abstract
21-Apr-14GlobalDataGlobalDataDiagnoCure Inc. (CUR) - Medical Equipment - Deals and Alliances Profile28$250  View Abstract
21-Apr-14GlobalDataGlobalDataNeuralstem, Inc. (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile29$250  View Abstract
19-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Neuralstem, Incorporation.40$75  View Abstract
19-Apr-14Reuters Investment ProfileN/AQuilicura SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
Next 20

Independent Reports (Showing 1 to 10 of 30)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
23-Apr-14New Constructs, LLCN/ACUR: Due Diligence Review: Forensic Earnings and Valuation5$25View Abstract
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - DIAGNOCURE INC. (CUR-T)11$25View Abstract
22-Apr-14Thomson Reuters Stock ReportN/AThomson Reuters Stock Report - NEURALSTEM, INCORPORATION. (CUR-A)11$25View Abstract
22-Apr-14Streetwise ReportsRaghuram SelvarajuNeuralstem Inc.: Moving from Strength to Strength2$11.50View Abstract
22-Apr-14Streetwise ReportsRaghuram SelvarajuDo the Math: Ram Selvaraju on the Appeal of Biotechs in Orphan Diseases11$115View Abstract
21-Apr-14GlobalDataGlobalDataDiagnoCure Inc. (CUR) - Medical Equipment - Deals and Alliances Profile28$250View Abstract
21-Apr-14GlobalDataGlobalDataNeuralstem, Inc. (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile29$250View Abstract
19-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Neuralstem, Incorporation.40$75View Abstract
19-Apr-14Reuters Investment ProfileN/AQuilicura SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.